Palazzo, L. Et Al. 2024. Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study. Rheumatology International , vol.44, no.10 , 1923-1933.

Palazzo, L., Lindblom, J., Kihlgren Olsson, E., Nikiphorou, E., Wincup, C., Saha, S., ... Katchamart, W.(2024). Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study. Rheumatology International , vol.44, no.10, 1923-1933.

Palazzo, Leonardo Et Al. "Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study," Rheumatology International , vol.44, no.10, 1923-1933, 2024

Palazzo, Leonardo Et Al. "Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study." Rheumatology International , vol.44, no.10, pp.1923-1933, 2024

Palazzo, L. Et Al. (2024) . "Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study." Rheumatology International , vol.44, no.10, pp.1923-1933.

@article{article, author={Leonardo Palazzo Et Al. }, title={Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study}, journal={Rheumatology International}, year=2024, pages={1923-1933} }